AGP Picks
View all

Alternative Medicine Times
Provided by AGP

Alternative Medicine Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alternative Medicine Times.

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

Press releases published on August 19, 2026

CIFTIS 2026: Vorschau auf die Höhepunkte des Bereichs Sportdienstleistungen
Aug. 19, 2026

CIFTIS 2026: Vorschau auf die Höhepunkte des Bereichs Sportdienstleistungen

Indeterminate GlobeNewswire
Section des services sportifs du CIFTIS 2026 : aperçu des temps forts
Aug. 19, 2026

Section des services sportifs du CIFTIS 2026 : aperçu des temps forts

Indeterminate GlobeNewswire
Yeast Market to Reach USD 10.14 Billion by 2031, Growing at a CAGR of 9.0% — MarketsandMarkets™
Aug. 19, 2026

Yeast Market to Reach USD 10.14 Billion by 2031, Growing at a CAGR of 9.0% — MarketsandMarkets™

Indeterminate GlobeNewswire
SafeSpace Global and BMRT Security Enter Binding Exclusive Agreement to Advance Detection of Concealed Weapons and Drugs for America’s Schools and Correctional Facilities
Aug. 19, 2026

SafeSpace Global and BMRT Security Enter Binding Exclusive Agreement to Advance Detection of Concealed Weapons and Drugs for America’s Schools and Correctional Facilities

Indeterminate GlobeNewswire
Imprivata Recognized in Constellation ShortList™ for Healthcare IT Security
Aug. 19, 2026

Imprivata Recognized in Constellation ShortList™ for Healthcare IT Security

Indeterminate GlobeNewswire
ACTG Evaluates Osteoporosis Treatment as Novel Approach Targeting the HIV Reservoir
Aug. 19, 2026

ACTG Evaluates Osteoporosis Treatment as Novel Approach Targeting the HIV Reservoir

Indeterminate GlobeNewswire
Roji Health Intelligence Releases New Guide as CMS Expands the Role of Accountable Care Organizations
Aug. 19, 2026

Roji Health Intelligence Releases New Guide as CMS Expands the Role of Accountable Care Organizations

Indeterminate GlobeNewswire
Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration
Aug. 19, 2026

Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration

Indeterminate GlobeNewswire
Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc®
Aug. 19, 2026

Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc®

Indeterminate GlobeNewswire
Regional Health Properties Reports Second Quarter 2026 Results
Aug. 19, 2026

Regional Health Properties Reports Second Quarter 2026 Results

Indeterminate GlobeNewswire
InterCure Ltd. Announces 1-for-5 Reverse Share Split
Aug. 19, 2026

InterCure Ltd. Announces 1-for-5 Reverse Share Split

Indeterminate GlobeNewswire
Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program Underway
Aug. 19, 2026

Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program Underway

Indeterminate GlobeNewswire
North Texas Food Bank Launches 13th Annual Peanut Butter Drive as Child Hunger Reaches New High
Aug. 19, 2026

North Texas Food Bank Launches 13th Annual Peanut Butter Drive as Child Hunger Reaches New High

Indeterminate GlobeNewswire
Earth Science Tech, Inc. (ETST) Acquires Zoolzy LLC to Drive Margin Expansion and Strategic Entry into the Veterinary Market
Aug. 19, 2026

Earth Science Tech, Inc. (ETST) Acquires Zoolzy LLC to Drive Margin Expansion and Strategic Entry into the Veterinary Market

Indeterminate GlobeNewswire
U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome
Aug. 19, 2026

U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome

Indeterminate GlobeNewswire
Food Encapsulation Market to Reach USD 21.79 Billion by 2030, Growing at a CAGR of 8.5% — MarketsandMarkets™
Aug. 19, 2026

Food Encapsulation Market to Reach USD 21.79 Billion by 2030, Growing at a CAGR of 8.5% — MarketsandMarkets™

Indeterminate GlobeNewswire
Biodexa announces major milestone for its Serenta registrational Phase 3 trial in FAP
Aug. 19, 2026

Biodexa announces major milestone for its Serenta registrational Phase 3 trial in FAP

Indeterminate GlobeNewswire
Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth
Aug. 19, 2026

Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth

Indeterminate GlobeNewswire
NOMAD Achieves UL 9540 Certification for 1 MW Transportable Battery Energy Storage System
Aug. 19, 2026

NOMAD Achieves UL 9540 Certification for 1 MW Transportable Battery Energy Storage System

Indeterminate GlobeNewswire
Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update
Aug. 19, 2026

Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Alternative Medicine Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.